Reports for SITAGLIPTIN

Ingredient

SITAGLIPTIN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207689
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207686
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-03-02 2023-10-06 185954
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-03-02 2023-10-06 185951
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2024-07-05 2024-08-09 232328
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185948
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2023-01-06 2023-07-27 180124
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185985
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185967

Showing 21 to 30 of 78

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
JANUMET 850MG 50MG TABLET To be discontinued 2024-12-12 2024-12-13 245516
STEGLUJAN 5MG 100MG TABLET Discontinued 2021-02-04 2021-02-04 133310
STEGLUJAN 15MG 100MG TABLET Discontinued 2021-02-04 2021-02-04 133307

Showing 1 to 3 of 3